PsygaBio

📍 North Industrial Park, Ceasarea, Israel🗓 Founded 2021👥 7 employees💰 Last funded Aug 2021
Research Services🌐 cannasoul.co.il
Website LinkedIn
PsygaBio is a drug discovery company focused on developing groundbreaking therapeutics derived from natural compounds. Founded by world-renowned cannabis and mushrooms researcher and pioneer Prof. Dedi Meiri from the Technion – Israel Institute of Technology and backed by robust scientific capabilities.   Psyga Bio using Cannasoul’s proprietary analytical platform, data-driven approach, unique knowhow and clinical trial framework supports active compound identification and development, from mushrooms cultivation and extraction through clinical approved formulations. 
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in PsygaBio?
PsygaBio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did PsygaBio last raise funding?
The most recent investment in PsygaBio recorded on gritt.io was in August 2021.
When was PsygaBio founded?
PsygaBio was founded in 2021.
What industry is PsygaBio in?
PsygaBio operates in Research Services. Find similar Research Services investors on gritt.io.
Where is PsygaBio based?
PsygaBio is headquartered in North Industrial Park, Ceasarea, Israel.